Skip to main content

Alpha Tau Medical Ltd.

DRTS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001871321

In the last 90 days, Alpha Tau Medical Ltd. insiders filed 0 open-market purchases and 6 sales; 74 institutions reported holding it in 13F filings for Q2 2026, worth $100.3M in total; ARK Invest is the only superinvestor holding it.

Other share classesDRTSW

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $823.3K in total
6
13F holdersQ2 2026, +21 vs. previous quarter
74
13F valueReported value at the end of Q2 2026
$100.3M
Superinvestors holdingAt the end of Q2 2026
1

Price chart

Superinvestors holding DRTS, Q2 2026

1 superinvestor reports holding Alpha Tau Medical Ltd. on Form 13F. Percentages are the stock's share of each portfolio.

Go to the superinvestors tab

ARK Invest

Cathie Wood

<0.1%

Alpha Tau Medical Ltd.'s share of the portfolio

Shares
277,086
Value
$3.49M

Latest insider trades

Open-market purchases and sales by Alpha Tau Medical Ltd. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 25, 2026 (view filing)10:34 AM ETAug 214 daysLevy RaphiChief Financial OfficerSSale−2.87K$15.00−$43.1K−3.1%90.2K after10b5-1
Aug 12, 2026 (view filing)12:18 PM ETAug 111 dayLevy RaphiChief Financial OfficerSSale−17.7K$14.00−$248.3K−16.4%90.2K after10b5-1
Jul 7, 2026 (view filing)7:49 AM ETJul 61 dayLevy RaphiChief Financial OfficerSSale−2.27K$14.00−$31.8K−2.5%90.2K after10b5-1
Jul 6, 2026 (view filing)11:37 AM ETJul 24 daysLevy RaphiChief Financial OfficerSSale−17.9K$13.00−$232.4K−16.5%90.2K after10b5-1
Jul 2, 2026 (view filing)11:45 AM ETJul 11 dayLevy RaphiChief Financial OfficerSSale−2.13K$13.02−$27.7K−2.3%90.2K after10b5-1
Jul 1, 2026 (view filing)8:21 AM ETJun 301 dayLevy RaphiChief Financial OfficerSSale−20.0K$12.00−$240.0K−18.2%90.2K after10b5-1
Jun 26, 2026 (view filing)Jun 251 dayLevy RaphiChief Financial OfficerSSale−20.0K$11.00−$220.0K−15.4%110.2K after2 lots10b5-1
Jun 25, 2026 (view filing)Jun 232 daysLevy RaphiChief Financial OfficerSSale−17.5K$9.55−$167.1K−11.8%130.2K after2 lots10b5-1
Jun 4, 2026 (view filing)Jun 31 dayLevy RaphiChief Financial OfficerSSale−32.5K$10.84−$352.1K−18.0%147.7K after2 lots

Top 10 13F holders, Q2 2026

The largest institutional positions in Alpha Tau Medical Ltd. at the end of Q2 2026; share changes are against Q1 2026.

See all 74 holders
Institutions holding DRTS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Gem Investment Advisors, LLC1,434,476$18.0M11.07%+1,320,740+1,161.2%Added
HighTower Advisors, LLC874,994$11.0M0.01%00.0%Unchanged
Boothbay Fund Management, LLC773,481$9.73M0.18%+773,481New
Aquamarine Financial (Cayman) Ltd721,501$9.08M0.50%00.0%Unchanged
Pier Capital, LLC691,939$8.70M1.15%+691,939New
UBS Group AG642,263$8.08M0.00%+355,575+124.0%Added
Apella Capital, LLC382,284$4.88M0.07%00.0%Unchanged
ARK Investment Management LLCSuperinvestorARK Invest277,086$3.49M0.02%−15,048−5.2%Reduced
Polen Capital Management LLC220,751$2.78M0.02%+220,751New
Colony Group, LLC184,726$2.32M0.00%+152,461+472.5%Added